** Shares of Tatva Chintan Pharma TATV.NS falls 10.6% to a
record low of 821 rupees
** Specialty chemicals maker posts Q2 loss of 6.6 million
rupees ($78,505.07) vs profit of 77.8 mln rupees a year ago
** TATV sees busiest day in more than a month, with over
183,000 shares traded
** Analysts' avg rating on stock is "hold" vs "buy" on peer
Gujarat Fluorochemicals GUJL.NS - LSEG
** Median PT on TATV is 1,021 rupees - LSEG
** Stock down 49% YTD vs 12% gain in GUJL
($1 = 84.0710 Indian rupees)
(Reporting by Aleef Jahan in Bengaluru)
((aleefjahan.cs@thomsonreuters.com))